LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

Home・Listă Acțiuni・United Therapeutics Corp

United Therapeutics Corp

Închisă

Sector Sănătate

373.77 -0.06

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

373.55

Maxim

375.61

Indicatori cheie
By Trading Economics
Venit	31M 309M
Vânzări	34M 749M
P/E Medie Sector	16.47 104.138
EPS	6.39
Marjă de profit	41.274
Angajați	1,168
EBITDA	42M 427M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+6.83 upside

Statistici piață
By TradingEconomics
Capitalizare de piață	447M 18B
Deschiderea anterioară	373.83
Închiderea anterioară	373.77

Sentimentul știrilor

By Acuity

91%

12 / 389 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bullish Evidence

352.58 / 375.175 Suport & Rezistență

United Therapeutics Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 oct. 2024, 15:14 UTC

Principalele dinamici ale pieței

Liquidia Shares Rise After Supreme Court Rejects United Therapeutics' Patent Appeal

Comparație

Modificare preț

United Therapeutics Corp Așteptări

Obiectiv de preț

By TipRanks

6.83% sus

Prognoză pe 12 luni

Medie 399.55 USD 6.83%

Maxim 600 USD

Minim 302 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruUnited Therapeutics Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

11 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 11 analiști care au acordat evaluări ale acțiunilor United Therapeutics Corp - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

352.58 / 375.175Suport & Rezistență

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

There are no events.

Sentiment

By Acuity

12 / 389 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre United Therapeutics Corp

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The Company market and sell four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution, which includes the Tyvaso Inhalation System; Orenitram (treprostinil) Extended-Release Tablets; and Adcirca (tadalafil) Tablets. In the United States, the Company also markets and sells an oncology product, Unituxin (dinutuximab) Injection, which is approved for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion.